• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合血浆和粪便代谢组学鉴定腺瘤-结直肠癌进展中的功能代谢物和早期诊断生物标志物。

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Yunnan Province Clinical Research Center for Digestive Disease, Yunan Geiatric Medical Center, Kunming, Yunnan, China.

Institute of Digestive Disease, Department of Medicine and Therapeutics, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, CUHK Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong SAR, China.

出版信息

Cancer Cell. 2024 Aug 12;42(8):1386-1400.e8. doi: 10.1016/j.ccell.2024.07.005.

DOI:10.1016/j.ccell.2024.07.005
PMID:
39137727
Abstract

Changes in plasma and fecal metabolomes in colorectal cancer (CRC) progression (normal-adenoma-CRC) remain unclear. Here, plasma and fecal samples were collected from four independent cohorts of 1,251 individuals (422 CRC, 399 colorectal adenoma [CRA], and 430 normal controls [NC]). By metabolomic profiling, signature plasma and fecal metabolites with consistent shift across NC, CRA, and CRC are identified, including CRC-enriched oleic acid and CRC-depleted allocholic acid. Oleic acid exhibits pro-tumorigenic effects in CRC cells, patient-derived organoids, and two murine CRC models, whereas allocholic acid has opposing effects. By integrative analysis, we found that oleic acid or allocholic acid directly binds to α-enolase or farnesoid X receptor-1 in CRC cells, respectively, to modulate cancer-associated pathways. Clinically, we establish a panel of 17 plasma metabolites that accurately diagnoses CRC in a discovery and three validation cohorts (AUC = 0.848-0.987). Overall, we characterize metabolite signatures, mechanistic significance, and diagnostic potential of plasma and fecal metabolomes in CRC.

摘要

血浆和粪便代谢组学在结直肠癌(CRC)进展(正常-腺瘤-CRC)中的变化仍不清楚。在这里,从四个独立的 1251 个人群(422 例 CRC、399 例结直肠腺瘤 [CRA] 和 430 例正常对照 [NC])中收集了血浆和粪便样本。通过代谢组学分析,鉴定出了在 NC、CRA 和 CRC 中具有一致变化的特征性血浆和粪便代谢物,包括 CRC 丰富的油酸和 CRC 耗尽的异胆酸。油酸在 CRC 细胞、患者来源的类器官和两种小鼠 CRC 模型中表现出促肿瘤作用,而异胆酸则具有相反的作用。通过综合分析,我们发现油酸或异胆酸分别直接与 CRC 细胞中的α-烯醇酶或法尼醇 X 受体-1 结合,从而调节与癌症相关的途径。临床上,我们建立了一个由 17 种血浆代谢物组成的panel,可在发现和三个验证队列中准确诊断 CRC(AUC=0.848-0.987)。总体而言,我们描述了 CRC 血浆和粪便代谢组学的代谢特征、机制意义和诊断潜力。

相似文献

1
Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.整合血浆和粪便代谢组学鉴定腺瘤-结直肠癌进展中的功能代谢物和早期诊断生物标志物。
Cancer Cell. 2024 Aug 12;42(8):1386-1400.e8. doi: 10.1016/j.ccell.2024.07.005.
2
Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.肠道代谢物的改变和微生物群落的相互作用与结直肠癌的发生有关,并且可以作为非侵入性的诊断生物标志物。
Microbiome. 2022 Feb 21;10(1):35. doi: 10.1186/s40168-021-01208-5.
3
A quantitative multimodal metabolomic assay for colorectal cancer.一种用于结直肠癌的定量多模态代谢组学分析方法。
BMC Cancer. 2018 Jan 4;18(1):26. doi: 10.1186/s12885-017-3923-z.
4
Gut microbiota and serum metabolite signatures along the colorectal adenoma-carcinoma sequence: Implications for early detection and intervention.结直肠腺瘤-癌序列中肠道微生物群和血清代谢物特征:早期检测和干预的意义。
Clin Chim Acta. 2024 Jun 15;560:119732. doi: 10.1016/j.cca.2024.119732. Epub 2024 May 19.
5
Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.多矩阵代谢组学分析用于结直肠癌和腺瘤的特异性检测。
Metabolomics. 2024 Apr 20;20(3):47. doi: 10.1007/s11306-024-02114-1.
6
[Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].[利用质子核磁共振波谱法识别粪便提取物中的代谢模式用于早期诊断结直肠癌]
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Sep 6;50(9):788-793. doi: 10.3760/cma.j.issn.0253-9624.2016.09.008.
7
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.结直肠腺瘤患者粪便代谢组学特征与肠道微生物群及结直肠癌发病早期事件相关。
mBio. 2020 Feb 18;11(1):e03186-19. doi: 10.1128/mBio.03186-19.
8
A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.一种经过验证的结直肠癌代谢组学特征:代谢组学临床价值探索
Br J Cancer. 2016 Sep 27;115(7):848-57. doi: 10.1038/bjc.2016.243. Epub 2016 Aug 25.
9
H NMR-based metabolomics reveal overlapping discriminatory metabolites and metabolic pathway disturbances between colorectal tumor tissues and fecal samples.基于 1H-NMR 的代谢组学揭示了结直肠肿瘤组织和粪便样本之间重叠的有区别代谢物和代谢途径紊乱。
Int J Cancer. 2019 Sep 15;145(6):1679-1689. doi: 10.1002/ijc.32190. Epub 2019 Mar 4.
10
Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.结直肠癌和腺瘤患者循环细菌 DNA 的改变:概念验证研究。
Cancer Lett. 2021 Feb 28;499:201-208. doi: 10.1016/j.canlet.2020.11.030. Epub 2020 Nov 27.

引用本文的文献

1
Clinical research, mechanisms, and prospects of flavonoids from Herba in the treatment of colorectal cancer.中药中黄酮类化合物治疗结直肠癌的临床研究、作用机制及前景
Front Pharmacol. 2025 Aug 28;16:1633286. doi: 10.3389/fphar.2025.1633286. eCollection 2025.
2
Emerging Understanding of Gut Microbiome in Colorectal Cancer and Food-Related Intervention Strategies.对结直肠癌中肠道微生物群的新认识及与食物相关的干预策略
Foods. 2025 Aug 29;14(17):3040. doi: 10.3390/foods14173040.
3
METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression.
METTL16促进脂质代谢重编程和结直肠癌进展。
Int J Biol Sci. 2025 Jul 24;21(11):4782-4797. doi: 10.7150/ijbs.105391. eCollection 2025.
4
Circulating proteins and metabolites panel for noninvasive preoperative diagnosis of epithelial ovarian cancer.用于上皮性卵巢癌术前无创诊断的循环蛋白和代谢物检测组
BMC Med. 2025 Aug 22;23(1):492. doi: 10.1186/s12916-025-04341-2.
5
Deciphering tryptophan metabolism in colorectal cancer through multi-omics analysis.通过多组学分析解析结直肠癌中的色氨酸代谢
Biochem Biophys Rep. 2025 Aug 12;43:102157. doi: 10.1016/j.bbrep.2025.102157. eCollection 2025 Sep.
6
Metabolic interactions: how gut microbial metabolites influence colorectal cancer.代谢相互作用:肠道微生物代谢产物如何影响结直肠癌
Front Microbiol. 2025 Jul 23;16:1611698. doi: 10.3389/fmicb.2025.1611698. eCollection 2025.
7
Lipid accumulation inhibition strategies alleviate Fusobacterium nucleatum-infected colorectal cancer.脂质蓄积抑制策略可缓解具核梭杆菌感染的结直肠癌。
Microbiome. 2025 Aug 6;13(1):181. doi: 10.1186/s40168-025-02133-7.
8
Gut microbiome and serum metabolome alterations in osteosarcoma patients.骨肉瘤患者的肠道微生物群和血清代谢组改变
Front Microbiol. 2025 Jul 17;16:1616603. doi: 10.3389/fmicb.2025.1616603. eCollection 2025.
9
Association of cumulative exposure to Chinese visceral adiposity index and gastrointestinal cancer: a prospective cohort study.中国内脏脂肪指数累积暴露与胃肠道癌症的关联:一项前瞻性队列研究。
Front Oncol. 2025 Jul 3;15:1534682. doi: 10.3389/fonc.2025.1534682. eCollection 2025.
10
Gut microbes and their metabolites in relation to the classic tumor suppressor gene P53: a novel narrative.肠道微生物及其代谢产物与经典肿瘤抑制基因P53的关系:一种新的叙述
NPJ Biofilms Microbiomes. 2025 Jul 17;11(1):135. doi: 10.1038/s41522-025-00775-x.